News Novartis AG

Equities

NOVN

CH0012005267

Pharmaceuticals

Market Closed - Swiss Exchange Other stock markets 10:00:05 14/01/2026 pm IST			5-day change	1st Jan Change
116.06 ^CHF	+2.13%		+2.17%	+5.89%

14/01	Dr. Reddy's Laboratories Launches Olopatadine Hydrochloride Ophthalmic Solution in US	MT
14/01	SciNeuro Grants Novartis Rights for Alzheimer's Disease Drug	MT

14/01	Dr. Reddy's Laboratories Launches Olopatadine Hydrochloride Ophthalmic Solution in US	MT
14/01	SciNeuro Grants Novartis Rights for Alzheimer's Disease Drug	MT
14/01	Swiss stocks - Factors to watch on January 14	RE
13/01	Travere shares fall as US FDA extends review of rare kidney disease drug	RE
13/01	Novartis eyes more bolt-on acquisitions, CEO says	RE
13/01	Global drugmakers rush to boost US presence as tariff threat looms	RE
13/01	Swiss stocks - Factors to watch on January 13	RE
13/01	Novartis Saudi Partners with Saudi Scientific Organization on Chronic Urticaria Awareness Campaign	MT
12/01	Novartis AG Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 09:00 AM
12/01	Novartis eyes more bolt-on acquisitions, CEO says	RE
12/01	Swiss Market Index Begins Week Flat; UBS, Novartis Edge Lower	MT
12/01	Novartis to Do Value-Creating Bolt-Ons	CI
12/01	SciNeuro, Novartis sign $1.7 billion licensing deal to develop Alzheimer's drugs	RE
12/01	Kyverna Therapeutics, Inc. Appoints Christi Shaw as Executive Chairperson of the Board, Effective January 12, 2026	CI
09/01	Novartis to Develop New US Radioligand Therapy Manufacturing Site in Florida	MT
09/01	Novartis to Build RLT Manufacturing Facility in Florida	MT
09/01	Novartis to Build Radioligand Therapy Facility in Florida	DJ
09/01	Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida	RE
09/01	Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment	DJ
09/01	Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment	DJ
09/01	Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment	GL
09/01	Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment	GL
09/01	Novartis to Add Radioligand Therapy Manufacturing Facility in Winter Park, Florida, Fourth in US to Serve Patients and Advance $23 Billion Investment	CI
09/01	Johnson & Johnson Reaches Deal With Trump Administration to Lower Drug Prices	DJ
08/01	Tango Therapeutics, Inc. Announces Board and Executive Changes	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Filters

Headlines

Novartis target price raised after upgrades

December 05, 2025 at 09:53 pm IST

Novartis CEO Says They Will Have to 'Tackle Rhetoric' in US Healthcare

January 21, 2025 at 04:26 pm IST